Evaluation of patient characteristics and treatment approaches to patients with bipolar disorder in Turkey
Study identifier:NIS-NTR-DUM-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Evaluation of patient characteristics and treatment approaches to patients with bipolar disorder in Turkey
Medical condition
Bipolar Disorder
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1018
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Mar 2008
Primary Completion Date: -
Study Completion Date: 01 Mar 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Patients with bipolar disorder | - |
Contacts
Investigators
Principal Investigator
Mustafa Bilici
Erenkoy State Hospital for Psychiatric Diseases, Istanbul, Turkey
